Review



addgene no 28023  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc addgene no 28023
    Addgene No 28023, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 36 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/addgene no 28023/product/Addgene inc
    Average 93 stars, based on 36 article reviews
    addgene no 28023 - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    Addgene inc addgene no 28023
    Addgene No 28023, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/addgene no 28023/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    addgene no 28023 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Addgene inc qing zhong
    Qing Zhong, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/qing zhong/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    qing zhong - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Addgene inc flag keap1
    a-b. qPCR analysis of ( a ) NQO1 and ( b ) HMOX1 gene expression in siCont or siNRF2 treated HBMEC and co-transduced with a control or TRIM47 lentivirus for 24h. Data were normalized to cyclophilin (n=3 experiments). * P<0.05; ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA. c. HO1 promoter luciferase reporter assay. TRIM47 cDNA expression plasmid (TRIM47) or empty expression plasmid (pcDNA) were co-transfected with HO1 promoter-luciferase constructs (HO1-4.5bp, HO1-4.5bp with 2 or 3 mutations) or a pGL3 empty vector in HeLa, and luciferase activity was measured. Values represent the fold change in relative luciferase activity over pGL3 vector (n=4 experiments). * P<0.05; ** P<0.01; **** P<0.0001, One-way ANOVA; ### P<0.001: compared to pGL3 + Lenti control condition, Student’s t-test. d. TRIM47 and <t>KEAP1</t> interaction was assessed by Co-IP assay in whole cell lysates from HEK293. Cells were transfected with TRIM47-myc pcDNA, KEAP1-Flag or both expression plasmids. Lysates were immunoprecipitated with myc antibody and immuno-blotted for myc (TRIM47) and KEAP1. e. Immunoblot and quantification of WB for NRF2 and KEAP1 in control and TRIM47-deficient HBMEC treated with DMSO or MG132 for 5h (n=4 experiments). Data were normalized to α-tubulin.* P<0.05; ** P<0.01, Student’s t-test. f-g. qPCR analysis of ( f ) NQO1 and ( g ) HMOX1 gene expression in HBMEC treated with control, TRIM47 or NRF2 siRNA for 72h and with tBHQ (10µM) for 24h (n=3 experiments). ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA; ##, P<0.01 Student’s t - test. All graphical data are mean ± s.e.m. h. Model of TRIM47 activation of the antioxidant NRF2 pathway in endothelial cells. 1. In basal conditions, TRIM47 binds to KEAP1 in the cytoplasm and thus alleviates KEAP1-dependent NRF2 degradation and increases NRF2 protein stabilization that can translocate to the nucleus to drive the expression of NRF2-target genes ( HMOX1 , NQO1 ) promoting cellular antioxidant protection. 2. In the absence of TRIM47 (TRIM47 siRNA condition), KEAP1 strongly binds to NRF2 leading to its ubiquitination and degradation by proteosomal complex, thus leading to the decreased of the protective NRF2 pathway.
    Flag Keap1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flag keap1/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    flag keap1 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Addgene inc full length
    a-b. qPCR analysis of ( a ) NQO1 and ( b ) HMOX1 gene expression in siCont or siNRF2 treated HBMEC and co-transduced with a control or TRIM47 lentivirus for 24h. Data were normalized to cyclophilin (n=3 experiments). * P<0.05; ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA. c. HO1 promoter luciferase reporter assay. TRIM47 cDNA expression plasmid (TRIM47) or empty expression plasmid (pcDNA) were co-transfected with HO1 promoter-luciferase constructs (HO1-4.5bp, HO1-4.5bp with 2 or 3 mutations) or a pGL3 empty vector in HeLa, and luciferase activity was measured. Values represent the fold change in relative luciferase activity over pGL3 vector (n=4 experiments). * P<0.05; ** P<0.01; **** P<0.0001, One-way ANOVA; ### P<0.001: compared to pGL3 + Lenti control condition, Student’s t-test. d. TRIM47 and <t>KEAP1</t> interaction was assessed by Co-IP assay in whole cell lysates from HEK293. Cells were transfected with TRIM47-myc pcDNA, KEAP1-Flag or both expression plasmids. Lysates were immunoprecipitated with myc antibody and immuno-blotted for myc (TRIM47) and KEAP1. e. Immunoblot and quantification of WB for NRF2 and KEAP1 in control and TRIM47-deficient HBMEC treated with DMSO or MG132 for 5h (n=4 experiments). Data were normalized to α-tubulin.* P<0.05; ** P<0.01, Student’s t-test. f-g. qPCR analysis of ( f ) NQO1 and ( g ) HMOX1 gene expression in HBMEC treated with control, TRIM47 or NRF2 siRNA for 72h and with tBHQ (10µM) for 24h (n=3 experiments). ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA; ##, P<0.01 Student’s t - test. All graphical data are mean ± s.e.m. h. Model of TRIM47 activation of the antioxidant NRF2 pathway in endothelial cells. 1. In basal conditions, TRIM47 binds to KEAP1 in the cytoplasm and thus alleviates KEAP1-dependent NRF2 degradation and increases NRF2 protein stabilization that can translocate to the nucleus to drive the expression of NRF2-target genes ( HMOX1 , NQO1 ) promoting cellular antioxidant protection. 2. In the absence of TRIM47 (TRIM47 siRNA condition), KEAP1 strongly binds to NRF2 leading to its ubiquitination and degradation by proteosomal complex, thus leading to the decreased of the protective NRF2 pathway.
    Full Length, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/full length/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    full length - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Addgene inc hek293t cells
    a-b. qPCR analysis of ( a ) NQO1 and ( b ) HMOX1 gene expression in siCont or siNRF2 treated HBMEC and co-transduced with a control or TRIM47 lentivirus for 24h. Data were normalized to cyclophilin (n=3 experiments). * P<0.05; ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA. c. HO1 promoter luciferase reporter assay. TRIM47 cDNA expression plasmid (TRIM47) or empty expression plasmid (pcDNA) were co-transfected with HO1 promoter-luciferase constructs (HO1-4.5bp, HO1-4.5bp with 2 or 3 mutations) or a pGL3 empty vector in HeLa, and luciferase activity was measured. Values represent the fold change in relative luciferase activity over pGL3 vector (n=4 experiments). * P<0.05; ** P<0.01; **** P<0.0001, One-way ANOVA; ### P<0.001: compared to pGL3 + Lenti control condition, Student’s t-test. d. TRIM47 and <t>KEAP1</t> interaction was assessed by Co-IP assay in whole cell lysates from HEK293. Cells were transfected with TRIM47-myc pcDNA, KEAP1-Flag or both expression plasmids. Lysates were immunoprecipitated with myc antibody and immuno-blotted for myc (TRIM47) and KEAP1. e. Immunoblot and quantification of WB for NRF2 and KEAP1 in control and TRIM47-deficient HBMEC treated with DMSO or MG132 for 5h (n=4 experiments). Data were normalized to α-tubulin.* P<0.05; ** P<0.01, Student’s t-test. f-g. qPCR analysis of ( f ) NQO1 and ( g ) HMOX1 gene expression in HBMEC treated with control, TRIM47 or NRF2 siRNA for 72h and with tBHQ (10µM) for 24h (n=3 experiments). ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA; ##, P<0.01 Student’s t - test. All graphical data are mean ± s.e.m. h. Model of TRIM47 activation of the antioxidant NRF2 pathway in endothelial cells. 1. In basal conditions, TRIM47 binds to KEAP1 in the cytoplasm and thus alleviates KEAP1-dependent NRF2 degradation and increases NRF2 protein stabilization that can translocate to the nucleus to drive the expression of NRF2-target genes ( HMOX1 , NQO1 ) promoting cellular antioxidant protection. 2. In the absence of TRIM47 (TRIM47 siRNA condition), KEAP1 strongly binds to NRF2 leading to its ubiquitination and degradation by proteosomal complex, thus leading to the decreased of the protective NRF2 pathway.
    Hek293t Cells, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hek293t cells/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    hek293t cells - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Addgene inc flag keap1 plasmid
    a-b. qPCR analysis of ( a ) NQO1 and ( b ) HMOX1 gene expression in siCont or siNRF2 treated HBMEC and co-transduced with a control or TRIM47 lentivirus for 24h. Data were normalized to cyclophilin (n=3 experiments). * P<0.05; ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA. c. HO1 promoter luciferase reporter assay. TRIM47 cDNA expression plasmid (TRIM47) or empty expression plasmid (pcDNA) were co-transfected with HO1 promoter-luciferase constructs (HO1-4.5bp, HO1-4.5bp with 2 or 3 mutations) or a pGL3 empty vector in HeLa, and luciferase activity was measured. Values represent the fold change in relative luciferase activity over pGL3 vector (n=4 experiments). * P<0.05; ** P<0.01; **** P<0.0001, One-way ANOVA; ### P<0.001: compared to pGL3 + Lenti control condition, Student’s t-test. d. TRIM47 and <t>KEAP1</t> interaction was assessed by Co-IP assay in whole cell lysates from HEK293. Cells were transfected with TRIM47-myc pcDNA, KEAP1-Flag or both expression plasmids. Lysates were immunoprecipitated with myc antibody and immuno-blotted for myc (TRIM47) and KEAP1. e. Immunoblot and quantification of WB for NRF2 and KEAP1 in control and TRIM47-deficient HBMEC treated with DMSO or MG132 for 5h (n=4 experiments). Data were normalized to α-tubulin.* P<0.05; ** P<0.01, Student’s t-test. f-g. qPCR analysis of ( f ) NQO1 and ( g ) HMOX1 gene expression in HBMEC treated with control, TRIM47 or NRF2 siRNA for 72h and with tBHQ (10µM) for 24h (n=3 experiments). ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA; ##, P<0.01 Student’s t - test. All graphical data are mean ± s.e.m. h. Model of TRIM47 activation of the antioxidant NRF2 pathway in endothelial cells. 1. In basal conditions, TRIM47 binds to KEAP1 in the cytoplasm and thus alleviates KEAP1-dependent NRF2 degradation and increases NRF2 protein stabilization that can translocate to the nucleus to drive the expression of NRF2-target genes ( HMOX1 , NQO1 ) promoting cellular antioxidant protection. 2. In the absence of TRIM47 (TRIM47 siRNA condition), KEAP1 strongly binds to NRF2 leading to its ubiquitination and degradation by proteosomal complex, thus leading to the decreased of the protective NRF2 pathway.
    Flag Keap1 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flag keap1 plasmid/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    flag keap1 plasmid - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Addgene inc human keap1 28023 addgene
    a-b. qPCR analysis of ( a ) NQO1 and ( b ) HMOX1 gene expression in siCont or siNRF2 treated HBMEC and co-transduced with a control or TRIM47 lentivirus for 24h. Data were normalized to cyclophilin (n=3 experiments). * P<0.05; ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA. c. HO1 promoter luciferase reporter assay. TRIM47 cDNA expression plasmid (TRIM47) or empty expression plasmid (pcDNA) were co-transfected with HO1 promoter-luciferase constructs (HO1-4.5bp, HO1-4.5bp with 2 or 3 mutations) or a pGL3 empty vector in HeLa, and luciferase activity was measured. Values represent the fold change in relative luciferase activity over pGL3 vector (n=4 experiments). * P<0.05; ** P<0.01; **** P<0.0001, One-way ANOVA; ### P<0.001: compared to pGL3 + Lenti control condition, Student’s t-test. d. TRIM47 and <t>KEAP1</t> interaction was assessed by Co-IP assay in whole cell lysates from HEK293. Cells were transfected with TRIM47-myc pcDNA, KEAP1-Flag or both expression plasmids. Lysates were immunoprecipitated with myc antibody and immuno-blotted for myc (TRIM47) and KEAP1. e. Immunoblot and quantification of WB for NRF2 and KEAP1 in control and TRIM47-deficient HBMEC treated with DMSO or MG132 for 5h (n=4 experiments). Data were normalized to α-tubulin.* P<0.05; ** P<0.01, Student’s t-test. f-g. qPCR analysis of ( f ) NQO1 and ( g ) HMOX1 gene expression in HBMEC treated with control, TRIM47 or NRF2 siRNA for 72h and with tBHQ (10µM) for 24h (n=3 experiments). ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA; ##, P<0.01 Student’s t - test. All graphical data are mean ± s.e.m. h. Model of TRIM47 activation of the antioxidant NRF2 pathway in endothelial cells. 1. In basal conditions, TRIM47 binds to KEAP1 in the cytoplasm and thus alleviates KEAP1-dependent NRF2 degradation and increases NRF2 protein stabilization that can translocate to the nucleus to drive the expression of NRF2-target genes ( HMOX1 , NQO1 ) promoting cellular antioxidant protection. 2. In the absence of TRIM47 (TRIM47 siRNA condition), KEAP1 strongly binds to NRF2 leading to its ubiquitination and degradation by proteosomal complex, thus leading to the decreased of the protective NRF2 pathway.
    Human Keap1 28023 Addgene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human keap1 28023 addgene/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    human keap1 28023 addgene - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Sino Biological flag-keap1 and ha-hspa9 overexpression plasmids
    a-b. qPCR analysis of ( a ) NQO1 and ( b ) HMOX1 gene expression in siCont or siNRF2 treated HBMEC and co-transduced with a control or TRIM47 lentivirus for 24h. Data were normalized to cyclophilin (n=3 experiments). * P<0.05; ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA. c. HO1 promoter luciferase reporter assay. TRIM47 cDNA expression plasmid (TRIM47) or empty expression plasmid (pcDNA) were co-transfected with HO1 promoter-luciferase constructs (HO1-4.5bp, HO1-4.5bp with 2 or 3 mutations) or a pGL3 empty vector in HeLa, and luciferase activity was measured. Values represent the fold change in relative luciferase activity over pGL3 vector (n=4 experiments). * P<0.05; ** P<0.01; **** P<0.0001, One-way ANOVA; ### P<0.001: compared to pGL3 + Lenti control condition, Student’s t-test. d. TRIM47 and <t>KEAP1</t> interaction was assessed by Co-IP assay in whole cell lysates from HEK293. Cells were transfected with TRIM47-myc pcDNA, KEAP1-Flag or both expression plasmids. Lysates were immunoprecipitated with myc antibody and immuno-blotted for myc (TRIM47) and KEAP1. e. Immunoblot and quantification of WB for NRF2 and KEAP1 in control and TRIM47-deficient HBMEC treated with DMSO or MG132 for 5h (n=4 experiments). Data were normalized to α-tubulin.* P<0.05; ** P<0.01, Student’s t-test. f-g. qPCR analysis of ( f ) NQO1 and ( g ) HMOX1 gene expression in HBMEC treated with control, TRIM47 or NRF2 siRNA for 72h and with tBHQ (10µM) for 24h (n=3 experiments). ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA; ##, P<0.01 Student’s t - test. All graphical data are mean ± s.e.m. h. Model of TRIM47 activation of the antioxidant NRF2 pathway in endothelial cells. 1. In basal conditions, TRIM47 binds to KEAP1 in the cytoplasm and thus alleviates KEAP1-dependent NRF2 degradation and increases NRF2 protein stabilization that can translocate to the nucleus to drive the expression of NRF2-target genes ( HMOX1 , NQO1 ) promoting cellular antioxidant protection. 2. In the absence of TRIM47 (TRIM47 siRNA condition), KEAP1 strongly binds to NRF2 leading to its ubiquitination and degradation by proteosomal complex, thus leading to the decreased of the protective NRF2 pathway.
    Flag Keap1 And Ha Hspa9 Overexpression Plasmids, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flag-keap1 and ha-hspa9 overexpression plasmids/product/Sino Biological
    Average 90 stars, based on 1 article reviews
    flag-keap1 and ha-hspa9 overexpression plasmids - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    a-b. qPCR analysis of ( a ) NQO1 and ( b ) HMOX1 gene expression in siCont or siNRF2 treated HBMEC and co-transduced with a control or TRIM47 lentivirus for 24h. Data were normalized to cyclophilin (n=3 experiments). * P<0.05; ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA. c. HO1 promoter luciferase reporter assay. TRIM47 cDNA expression plasmid (TRIM47) or empty expression plasmid (pcDNA) were co-transfected with HO1 promoter-luciferase constructs (HO1-4.5bp, HO1-4.5bp with 2 or 3 mutations) or a pGL3 empty vector in HeLa, and luciferase activity was measured. Values represent the fold change in relative luciferase activity over pGL3 vector (n=4 experiments). * P<0.05; ** P<0.01; **** P<0.0001, One-way ANOVA; ### P<0.001: compared to pGL3 + Lenti control condition, Student’s t-test. d. TRIM47 and KEAP1 interaction was assessed by Co-IP assay in whole cell lysates from HEK293. Cells were transfected with TRIM47-myc pcDNA, KEAP1-Flag or both expression plasmids. Lysates were immunoprecipitated with myc antibody and immuno-blotted for myc (TRIM47) and KEAP1. e. Immunoblot and quantification of WB for NRF2 and KEAP1 in control and TRIM47-deficient HBMEC treated with DMSO or MG132 for 5h (n=4 experiments). Data were normalized to α-tubulin.* P<0.05; ** P<0.01, Student’s t-test. f-g. qPCR analysis of ( f ) NQO1 and ( g ) HMOX1 gene expression in HBMEC treated with control, TRIM47 or NRF2 siRNA for 72h and with tBHQ (10µM) for 24h (n=3 experiments). ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA; ##, P<0.01 Student’s t - test. All graphical data are mean ± s.e.m. h. Model of TRIM47 activation of the antioxidant NRF2 pathway in endothelial cells. 1. In basal conditions, TRIM47 binds to KEAP1 in the cytoplasm and thus alleviates KEAP1-dependent NRF2 degradation and increases NRF2 protein stabilization that can translocate to the nucleus to drive the expression of NRF2-target genes ( HMOX1 , NQO1 ) promoting cellular antioxidant protection. 2. In the absence of TRIM47 (TRIM47 siRNA condition), KEAP1 strongly binds to NRF2 leading to its ubiquitination and degradation by proteosomal complex, thus leading to the decreased of the protective NRF2 pathway.

    Journal: bioRxiv

    Article Title: Cerebral Small Vessel Disease genetic determinant TRIM47 controls brain homeostasis via the NRF2 antioxidant system

    doi: 10.1101/2024.10.08.616723

    Figure Lengend Snippet: a-b. qPCR analysis of ( a ) NQO1 and ( b ) HMOX1 gene expression in siCont or siNRF2 treated HBMEC and co-transduced with a control or TRIM47 lentivirus for 24h. Data were normalized to cyclophilin (n=3 experiments). * P<0.05; ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA. c. HO1 promoter luciferase reporter assay. TRIM47 cDNA expression plasmid (TRIM47) or empty expression plasmid (pcDNA) were co-transfected with HO1 promoter-luciferase constructs (HO1-4.5bp, HO1-4.5bp with 2 or 3 mutations) or a pGL3 empty vector in HeLa, and luciferase activity was measured. Values represent the fold change in relative luciferase activity over pGL3 vector (n=4 experiments). * P<0.05; ** P<0.01; **** P<0.0001, One-way ANOVA; ### P<0.001: compared to pGL3 + Lenti control condition, Student’s t-test. d. TRIM47 and KEAP1 interaction was assessed by Co-IP assay in whole cell lysates from HEK293. Cells were transfected with TRIM47-myc pcDNA, KEAP1-Flag or both expression plasmids. Lysates were immunoprecipitated with myc antibody and immuno-blotted for myc (TRIM47) and KEAP1. e. Immunoblot and quantification of WB for NRF2 and KEAP1 in control and TRIM47-deficient HBMEC treated with DMSO or MG132 for 5h (n=4 experiments). Data were normalized to α-tubulin.* P<0.05; ** P<0.01, Student’s t-test. f-g. qPCR analysis of ( f ) NQO1 and ( g ) HMOX1 gene expression in HBMEC treated with control, TRIM47 or NRF2 siRNA for 72h and with tBHQ (10µM) for 24h (n=3 experiments). ** P<0.01; *** P<0.001; **** P<0.0001, One-way ANOVA; ##, P<0.01 Student’s t - test. All graphical data are mean ± s.e.m. h. Model of TRIM47 activation of the antioxidant NRF2 pathway in endothelial cells. 1. In basal conditions, TRIM47 binds to KEAP1 in the cytoplasm and thus alleviates KEAP1-dependent NRF2 degradation and increases NRF2 protein stabilization that can translocate to the nucleus to drive the expression of NRF2-target genes ( HMOX1 , NQO1 ) promoting cellular antioxidant protection. 2. In the absence of TRIM47 (TRIM47 siRNA condition), KEAP1 strongly binds to NRF2 leading to its ubiquitination and degradation by proteosomal complex, thus leading to the decreased of the protective NRF2 pathway.

    Article Snippet: Flag-Keap1 was a gift from Qing Zhong (Addgene plasmid #28023; http://n2t.net/addgene:28023 ; RRID:Addgene_28023). pCDNA3-Myc3-Nrf2 was a gift from Yue Xiong (Addgene plasmid #21555; http://n2t.net/addgene:21555 ; RRID:Addgene_21555). pHOGL3/4.5 and pHOGL3/4.5 Triple mutant plasmids were a gift from Prof. Anupam Agarwal (University of Alabama at Birmingham, US).

    Techniques: Expressing, Transduction, Control, Luciferase, Reporter Assay, Plasmid Preparation, Transfection, Construct, Activity Assay, Co-Immunoprecipitation Assay, Immunoprecipitation, Western Blot, Activation Assay